Search

Search Constraints

You searched for: Author/Creator Loyo Esthela author non-byline.

Search Results

1. A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study. Issue 1 (23rd October 2014)

2. Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort. Issue 2 (3rd November 2022)

3. Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group. Issue 6 (17th January 2014)

4. Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database. Issue 7 (31st July 2015)

5. Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study. Issue 7 (9th April 2019)

6. Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study. Issue 7 (9th July 2019)

7. Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis. Issue 10 (25th March 2016)

8. Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database. Issue 6 (30th June 2014)

9. Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis. Issue 9 (21st June 2019)

10. Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis. Issue 9 (21st September 2019)